Skip to main content

Table 1 Patient demographics, by transplanting hospital

From: Evaluating risk factors for Clostridium difficile infection in adult and pediatric hematopoietic cell transplant recipients

 

Pediatric transplants

Adult transplants

Characteristic

(n =192)

(n =990)

Age (yr) – median (IQR)

11 (6, 15)

52 (42, 61)

Sex: male – n (%)

104 (54)

583 (59)

Race/Ethnicity – n (%)

  

Caucasian

101 (53)

761 (77)

Hispanic

31 (17)

27 (3)

Asian Pacific-Islander

19 (10)

59 (6)

Black

6 (3)

17 (2)

Native American

2 (1)

8 (1)

Other

22 (12)

53 (5)

Unknown

11 (6)

65 (7)

Underlying Disease – n (%)

  

ALL

67 (35)

107 (11)

AML

34 (18)

341 (34)

MDS

12 (6)

206 (21)

NHL

7 (4)

107 (11)

CML

6 (3)

36 (4)

HD

1 (1)

30 (3)

Other

65 (34)

163 (17)

Stem cell source – n (%)

  

Bone marrow

102 (53)

155 (16)

PBSC

36 (19)

743 (75)

Cord blood

54 (28)

92 (9)

Donor – n (%)

  

Sibling

52 (27)

300 (30)

Unrelated

80 (42)

523 (53)

Cord

54 (28)

92 (9)

Haploidentical

6 (3)

68 (7)

Conditioning regimen – n (%)

  

Myeloablative

175 (91)

559 (57)

Nonmyeloablative

17 (9)

431 (44)

GVHD prophylaxis – n (%)

  

CSP or FK506, with MTX

106 (55)

360 (36)

MMF regimen

74 (39)

539 (54)

Other/none

12 (6)

91 (9)

Inpatient daysa – median (IQR)

41 (31, 55)

18 (5, 28)

  1. Abbreviations: IQR (interquartile range), ALL (acute lymphoblastic leukemia), AML (acute myeloid leukemia), MDS (myelodysplastic syndrome), NHL (non-Hodgkin lymphoma), CML (chronic myeloid leukemia), HD (Hodgkin’s lymphoma), PBSC (peripheral blood stem cells), GVHD (graft-versus-host disease), CSP (cyclosporine), FK506 (tacrolimus), MTX (methotrexate), MMF (mycophenolate mofetil)
  2. aWhile under observation (i.e. prior to censorship)